Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Value-based price estimates provide context around value-based contracting negotiations, because they represent the total per patient social value produced by the drug
Proc Natl Acad Sci U S A , 98: 34103405, 2001
PD has received consulting fees/honoraria from Novo Nordisk, Eli Lilly, Sanofi, AstraZeneca, Boehringer Ingelheim, Mundipharma, Merck Sharp & Dohme, Bayer, Abbott, LVL Medical, and Bastide
However, we welcome the governments new direction to prescribers that there is now sufficient stock of Rybelsus to allow new initiation of this medication and hope that many people with T2DM who could benefit will now be able to be initiated onto a GLP-1 for the first time
US$ 29.69
US$ 27.52
US$ 21.98
US$ 25.11
US$ 25.20
US$ 29.12
US$ 28.44
